4.8 Article

CSDE1 attenuates microRNA-mediated silencing of PMEPA1 in melanoma

期刊

ONCOGENE
卷 40, 期 18, 页码 3231-3244

出版社

SPRINGERNATURE
DOI: 10.1038/s41388-021-01767-9

关键词

-

资金

  1. Canadian Institutes of Health Research (CIHR)
  2. Fonds de Recherche du Quebec-Sante (FRQ-S)
  3. CIHR [FDN-143213]
  4. Spanish Ministry of Science and Innovation (MICINN) [PGC2018-099697-B-I00]
  5. la Caixa Foundation [100010434, LCF/PR/HR17/52150016]
  6. Catalan Government [2017SGR534]
  7. Center of Excellence Severo Ochoa

向作者/读者索取更多资源

The study reveals that CSDE1 interacts with miRNA-induced silencing complex miRISC in melanoma, affecting the expression of PMEPA1 gene by binding with AGO2. Additionally, miRNA miR-129-5p also represses PMEPA1 expression in melanoma, collectively regulating the impact of PMEPA1 on the progression of melanoma.
MicroRNAs and RNA-binding proteins (RBPs) primarily target the 3 ' UTR of mRNAs to control their translation and stability. However, their co-regulatory effects on specific mRNAs in physiology and disease are yet to be fully explored. CSDE1 is an RBP that promotes metastasis in melanoma and mechanisms underlying its oncogenic activities need to be completely defined. Here we report that CSDE1 interacts with specific miRNA-induced silencing complexes (miRISC) in melanoma. We find an association of CSDE1 with AGO2, the essential component of miRISC, which is facilitated by target mRNAs and depends on the first cold shock domain of CSDE1. Both CSDE1 and AGO2 bind to 3 ' UTR of PMEPA1. CSDE1 counters AGO2 binding, leading to an increase of PMEPA1 expression. We also identify a miRNA, miR-129-5p, that represses PMEPA1 expression in melanoma. Collectively, our results show that PMEPA1 promotes tumorigenic traits and that CSDE1 along with miR-129-5p/AGO2 miRISC act antagonistically to fine-tune PMEPA1 expression toward the progression of melanoma.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据